1. Home
  2. WST vs TW Comparison

WST vs TW Comparison

Compare WST & TW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • TW
  • Stock Information
  • Founded
  • WST 1923
  • TW 1996
  • Country
  • WST United States
  • TW United States
  • Employees
  • WST N/A
  • TW N/A
  • Industry
  • WST Medical/Dental Instruments
  • TW Investment Bankers/Brokers/Service
  • Sector
  • WST Health Care
  • TW Finance
  • Exchange
  • WST Nasdaq
  • TW Nasdaq
  • Market Cap
  • WST 15.6B
  • TW 28.0B
  • IPO Year
  • WST N/A
  • TW 2019
  • Fundamental
  • Price
  • WST $222.00
  • TW $139.51
  • Analyst Decision
  • WST Buy
  • TW Strong Buy
  • Analyst Count
  • WST 7
  • TW 11
  • Target Price
  • WST $331.67
  • TW $149.64
  • AVG Volume (30 Days)
  • WST 696.4K
  • TW 1.3M
  • Earning Date
  • WST 07-24-2025
  • TW 07-30-2025
  • Dividend Yield
  • WST 0.38%
  • TW 0.35%
  • EPS Growth
  • WST N/A
  • TW 29.22
  • EPS
  • WST 6.37
  • TW 2.43
  • Revenue
  • WST $2,895,800,000.00
  • TW $1,823,739,000.00
  • Revenue This Year
  • WST $3.38
  • TW $23.19
  • Revenue Next Year
  • WST $5.85
  • TW $11.08
  • P/E Ratio
  • WST $34.87
  • TW $57.19
  • Revenue Growth
  • WST N/A
  • TW 28.94
  • 52 Week Low
  • WST $187.43
  • TW $103.43
  • 52 Week High
  • WST $352.33
  • TW $152.65
  • Technical
  • Relative Strength Index (RSI)
  • WST 55.47
  • TW 46.41
  • Support Level
  • WST $215.67
  • TW $133.40
  • Resistance Level
  • WST $226.80
  • TW $146.51
  • Average True Range (ATR)
  • WST 5.26
  • TW 3.66
  • MACD
  • WST -0.05
  • TW -0.09
  • Stochastic Oscillator
  • WST 65.84
  • TW 42.56

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in U.S. and European government debt, mortgage-backed securities, interest-rate swaps, and U.S. and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

Share on Social Networks: